WSJ Sunday Personal Finance Columnist Jonathan Clements on the benefits of a potential pullback in the markets and strategies for re-allocating your portfolio.
InterDigital CEO William Merritt talks business in the technology industry.
FBN’s David Asman on Novartis ’ partnership with Google, Facebook’s plans to track users’ TV habits and Morgan Stanley’s report on the potential Apple iWatch.
Aratana Therapeutics CEO Steven St. Peter on what’s driving growth in the animal-health business.
Eli Lilly CEO John Lechleiter argues the company doesn’t need to make bid deals to grow.
Ford CEO Alan Mulally on technology in cars, the leadership transition at the automaker and balancing his work and family life.
Markets.com chief economist Bill Hubard with the latest on the European markets.
John Eade of the Argus Research Company and Mizuho chief investments strategist Carmine Grigoli discuss the M&A market and where the growth is.
The Vinnie from Queens panel weighs in on the NFL draft and the NBA playoffs.
AstraZeneca announced faster-than-expected progress of its experimental cancer drugs and plans to spin off billions of dollars of non-core assets as it staked a clai...
Medical device maker Zimmer Holdings Inc said it would buy orthopedic products company Biomet Inc in a deal valued at about $13.35 billion to broaden its portfolio o...
The loud welcome given by investors to this week's deal for Novartis and GlaxoSmithKline to trade more than $20 billion of assets could trigger more pacts in the pha...
Robert W. Baird & Co. senior analyst Brian Skorney on what investors can expect from pharma in the second quarter.
Claman on Call: FBN’s Liz Claman with an after-hours web exclusive on the markets, the midterm elections, Novartis ’ on the brink of treatments for cancer and heart failure and the earnings to watch for tomorrow.
Former Kansas Governor Mark Parkinson and Former Maryland Governor Robert Ehrlich say the key races for Republicans are New Hampshire and North Carolina.
Novartis CEO Joseph Jimenez says the company is working on finding a cure for cancer and bringing a revolutionary heart drug to market by 2015.
Radiation oncologist Dr. Elizabeth Chabner Thompson on the high price tags in the fight against cancer.
The Real Housewives of New York City's Heather Thomson and The Wall Street Journal’s Veronica Dagher on the new robot that could help you with the dishes and a Dutch teen's unique drone.
FBN’s Lauren Simonetti on Compuware and Novartis ’ new heart failure drug.
Eli Lilly CEO John Lechleiter discusses 2Q earnings and the impact of recent patent expirations.